ReviewVirology journal2025
Oropouche virus: molecular virological characteristics and research progress of a neglected arbovirus.
Review in Virology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Review
- Next-Generation HIV-1 Therapeutics in Co-Endemic Settings.Biomedicines · 2026Review
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oropouche, second only to dengue, a public health concern in the Amazon Basin of South America, has caused multiple localized outbreaks since its initial identification in 1955. Recurrent epidemics have been reported across various regions, with over 500,000 confirmed cases reported to date [De lima STS, Hua X, Claro IM 31(4):838-42, 2025, Almeida JD, Tyrrell DA, 1(2):175-8, 1967]. From late 2023 to early 2024, the geographic range of OROV rapidly expanded, Epidemiological data indicate that the geographical spread of the virus has extended beyond endemic regions such as Bolivia, Brazil, Colombia, Peru, with imported cases successively reported in non-endemic areas including Italy and the United States, confirming its significant potential for cross-border transmission and global dissemination [Castilletti C, Mori A, Matucci A, 29(26), 2024, Benitez A J, Alvarez M, Perez L, 30(10): 2155-9, 2024]. Currently, there are notable gaps in surveillance networks and control capabilities for this pathogen, alongside a scarcity of fundamental research and countermeasures. Recent outbreaks have heightened concerns, as they not only threaten to overwhelm local healthcare systems but also raise alarms about the potential escalation to regional epidemics and even global public health emergencies. Through a comprehensive analysis of existing literature, this review systematically synthesizes current knowledge on the molecular characteristics, epidemiology, and available detection and treatment methods of the virus. It reveals substantial gaps in the understanding of its pathogenic mechanisms and transmission dynamics. There is an urgent need to enhance viral surveillance, advance translational research from basic virology to clinical applications, and accelerate the development of medical countermeasures-including diagnostic reagents, vaccines, and antiviral therapies-to effectively mitigate the potential public health threat posed by this pathogen. Currently, surveillance and control measures for OROV remain limited. Despite its significant impact, research on OROV is scarce. Recent outbreaks may overwhelm local healthcare systems, raising concerns about the risk of regional epidemics and even potential public health emergencies worldwide. This review synthesizes current knowledge on the molecular virology and epidemiology of OROV, emphasizing the urgent need for enhanced surveillance, as well as accelerated research into its pathogenesis, vaccines, and therapeutics to mitigate the threat posed by this emerging arbovirus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.